- Home
- SWBI vs ZBIO Comparison
SWBI vs ZBIO Comparison
Compare SWBI & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWBI
- ZBIO
- Stock Information
- Founded
- SWBI 1852
- ZBIO 2019
- Country
- SWBI United States
- ZBIO United States
- Employees
- SWBI N/A
- ZBIO N/A
- Industry
- SWBI Ordnance And Accessories
- ZBIO
- Sector
- SWBI Industrials
- ZBIO
- Exchange
- SWBI Nasdaq
- ZBIO NYSE
- Market Cap
- SWBI 429.0M
- ZBIO 389.2M
- IPO Year
- SWBI N/A
- ZBIO 2024
- Fundamental
- Price
- SWBI $9.78
- ZBIO $11.12
- Analyst Decision
- SWBI Buy
- ZBIO Strong Buy
- Analyst Count
- SWBI 2
- ZBIO 7
- Target Price
- SWBI $12.75
- ZBIO $32.29
- AVG Volume (30 Days)
- SWBI 295.4K
- ZBIO 135.6K
- Earning Date
- SWBI 06-20-2025
- ZBIO 06-17-2025
- Dividend Yield
- SWBI 5.32%
- ZBIO N/A
- EPS Growth
- SWBI 16.02
- ZBIO N/A
- EPS
- SWBI 0.66
- ZBIO N/A
- Revenue
- SWBI $493,046,000.00
- ZBIO $15,000,000.00
- Revenue This Year
- SWBI N/A
- ZBIO $206.00
- Revenue Next Year
- SWBI $3.86
- ZBIO $77.40
- P/E Ratio
- SWBI $14.79
- ZBIO N/A
- Revenue Growth
- SWBI N/A
- ZBIO N/A
- 52 Week Low
- SWBI $8.38
- ZBIO $5.83
- 52 Week High
- SWBI $16.85
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- SWBI 58.60
- ZBIO N/A
- Support Level
- SWBI $9.46
- ZBIO N/A
- Resistance Level
- SWBI $9.87
- ZBIO N/A
- Average True Range (ATR)
- SWBI 0.19
- ZBIO 0.00
- MACD
- SWBI 0.02
- ZBIO 0.00
- Stochastic Oscillator
- SWBI 85.08
- ZBIO 0.00
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.